Demographic, clinical, and laboratory features of Turkish patients with gouty arthritis: A prospective cohort study.
Journal
European journal of rheumatology
ISSN: 2147-9720
Titre abrégé: Eur J Rheumatol
Pays: Turkey
ID NLM: 101656068
Informations de publication
Date de publication:
Jan 2019
Jan 2019
Historique:
received:
11
10
2018
accepted:
14
11
2018
entrez:
12
4
2019
pubmed:
12
4
2019
medline:
12
4
2019
Statut:
ppublish
Résumé
We have conducted this study to evaluate clinical and laboratory findings and to gather and evaluate information that would be useful in clinical practice, such as demographics, joint involvement patterns, laboratory anomalies, treatments applied, and responses obtained in patients diagnosed with gout. In our study, the demographic, clinical, and laboratory characteristics of 94 patients diagnosed with gout were evaluated. The patients were re-evaluated with regard to their clinical and laboratory findings at the end of the 1 Seventy-nine (84%) of the patients were men, and 15 (16%) were women. The ages of the patients ranged between 22 and 86 years with the average age being 57.5 years. The joint involvement during a gouty arthritis attack was most frequently observed in the 1st metatarsophalangeal joint (87.2%), followed by the ankle joint (26.9%), and the knee joint (23.7%). The joint involvement pattern was evaluated to reveal that the acute monoarticular arthritis was observed in 87 patients (93.5%), followed by acute oligoarticular arthritis coming in second in terms of frequency (26.9%). An average attack was determined to last 10.7 days, and the average number of attacks in a year was 2.69. In our study, the colchicine treatment in 24 of our patients, in whom it was determined during the admission and follow-up process that they have not had gouty arthritis attack in the past 3 months, was stopped. Five (20.8%) patients whose colchicine treatment was stopped later developed gouty arthritis attacks, and the colchicine treatment was restarted. On the other hand, 10 out of 38 patients (26.3%), who have either been continuing or had never been on colchicine treatment, were observed to experience a gouty arthritis attack during their 1st and 3rd month check-ups. In patients with gout, it is recommended that the related diseases, as well as the triggering factors (alcohol, drug use, and dietary effect), be determined, the necessary lifestyle changes be made, and the treatments started.
Identifiants
pubmed: 30973321
pii: eurjrheum.2018.18149
doi: 10.5152/eurjrheum.2018.18149
pmc: PMC6459326
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1-6Références
Health Qual Life Outcomes. 2003 Jun 09;1:20
pubmed: 12831398
J Rheumatol. 2004 Dec;31(12):2429-32
pubmed: 15570646
J Rheumatol. 2005 Nov;32(11):2189-91
pubmed: 16265701
Arthritis Res Ther. 2006;8 Suppl 1:S1
pubmed: 16820040
Arthritis Res Ther. 2006;8 Suppl 1:S2
pubmed: 16820041
Ann Rheum Dis. 2008 Jul;67(7):960-6
pubmed: 17981913
Arthritis Rheum. 2008 May 15;59(5):665-9
pubmed: 18438898
J Rheumatol. 2009 Sep;36(9):1958-62
pubmed: 19605673
Arthritis Res Ther. 2011 Mar 03;13(2):R39
pubmed: 21371293
BMC Musculoskelet Disord. 2011 May 20;12:103
pubmed: 21599917
J Rheumatol. 2014 Oct;41(10):1910-2
pubmed: 25179848
Nephrol Dial Transplant. 2015 Apr;30(4):613-21
pubmed: 25395390
Arthritis Care Res (Hoboken). 2015 Sep;67(9):1304-15
pubmed: 25777045
Arthritis Res Ther. 2015 Apr 01;17:90
pubmed: 25889144
BMC Musculoskelet Disord. 2016 Feb 11;17:69
pubmed: 26864742